Clinical Trial: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07227298) titled 'A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers' on Nov. 07.

Brief Summary: This study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanced solid tumors. An advanced solid tumor is a type of cancer that has spread beyond its original location and cannot be removed by surgery or cured with standard treatments.

To join in the study, participants must:

* Be 18 years or older

* Participants with advanced non-small cell lung cancer (NSCLC), a type of lung can...